Symbol="VNDA"
AssetType="Common Stock"
Name="Vanda Pharmaceuticals Inc"
Description="Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia."
CIK="1347178"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="346388000"
EBITDA="18703000"
PERatio="21.54"
PEGRatio="-2.42"
BookValue="9.33"
DividendPerShare="0"
DividendYield="0"
EPS="0.28"
RevenuePerShareTTM="4.528"
ProfitMargin="0.0622"
OperatingMarginTTM="0.0623"
ReturnOnAssetsTTM="0.016"
ReturnOnEquityTTM="0.0308"
RevenueTTM="256688000"
GrossProfitTTM="230100000"
DilutedEPSTTM="0.28"
QuarterlyEarningsGrowthYOY="-0.006"
QuarterlyRevenueGrowthYOY="0.038"
AnalystTargetPrice="7"
TrailingPE="21.54"
ForwardPE="30.3"
PriceToSalesRatioTTM="1.532"
PriceToBookRatio="1.153"
EVToRevenue="0.586"
EVToEBITDA="13.6"
Beta="0.694"
num_52WeekHigh="11.74"
num_52WeekLow="5.75"
num_50DayMovingAverage="6.36"
num_200DayMovingAverage="7.71"
SharesOutstanding="57444000"
DividendDate="None"
ExDividendDate="None"
symbol="VNDA"
open="6.07"
high="6.11"
low="5.93"
price="6.03"
volume="380594.00"
latest_trading_day="2023-07-14"
previous_close="6.03"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="40"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="584910"
Change_recent_avg="-0.02"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="1088"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_negative_thumbnail_id_2="130"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="638"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0070.jpeg"
image_positive_thumbnail_id_2="694"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
